Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arena Pharmaceuticals
(NQ:
ARNA
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 10, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arena Pharmaceuticals
< Previous
1
2
3
4
Next >
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 18, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Cannabis Stock Gainers And Losers From June 17, 2021
June 17, 2021
GAINERS: Invictus MD Strategies (OT...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Steven Schoch Elected to Arena Pharmaceuticals Board of Directors
June 14, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Earnings Scheduled For May 5, 2021
May 05, 2021
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT...
Via
Benzinga
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge
May 01, 2021
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...
Via
Benzinga
Exposures
Product Safety
Cannabis Stock Gainers And Losers From June 10, 2021
June 10, 2021
GAINERS: Cipher Pharms Inc (OTC:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Arena Pharmaceuticals Announces Orphan Drug Designation for Etrasimod for the Treatment of Eosinophilic Esophagitis (EoE)
June 09, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Arena Pharmaceuticals Announces First Participant Randomized in Phase 2 Trial Evaluating Temanogrel in Coronary Microvascular Obstruction (cMVO)
June 08, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Rapid Development of Cannabinoid Based Medicinal Products Reaching New Levels
June 08, 2021
Via
FinancialNewsMedia
Topics
Cannabis
Economy
Exposures
COVID-19
Cannabis
Economy
Arena Pharmaceuticals Earns "A" Rating from MSCI ESG, a Leading Rating Agency for Sustainable Investments
June 03, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 19, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2021
May 18, 2021
Upgrades Janney Montgomery Scott upgraded the previous rating for Centerspace (NYSE:CSR) from Neutral to Buy. In the first quarter, Centerspace showed an EPS of $0.95,...
Via
Benzinga
Arena Pharmaceuticals Earns Prime Status from ISS ESG, a Leading Rating Agency for Sustainable Investments
May 12, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Arena Pharmaceuticals Inc (ARNA) Q1 2021 Earnings Call Transcript
May 06, 2021
ARNA earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Arena Reports First Quarter Financial Results with Strong Cash Position and Continued Progress on Pipeline Over the Quarter
May 05, 2021
From
ARENA Pharmaceuticals
Via
Business Wire
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
May 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Arena Pharmaceuticals to Release First Quarter 2021 Financial Results and Provide Corporate Update on May 5
April 28, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 27, 2021
April 27, 2021
Upgrades According to JP Morgan, the prior rating for BP Midstream Partners LP (NYSE:BPMP) was changed from Neutral to Overweight. For the fourth quarter, BP Midstream...
Via
Benzinga
Arena Pharmaceuticals Presents Clinician and Patient Reported Outcomes Data from Phase 2b ADVISE Trial Evaluating Etrasimod in Adult Atopic Dermatitis During a Late-Breaking Session at American Academy of Dermatology VMX
April 23, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Arena Pharmaceuticals Releases Second Annual Environmental, Social and Governance (ESG) Report
April 19, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
April 23, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:...
Via
Benzinga
Arena Pharmaceuticals to Present Data from the Phase 2b ADVISE Trial During Late-Breaking Research Session at American Academy of Dermatology Virtual Meeting Experience
April 19, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 16, 2021
From
Arena Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.